Search

5472 results for: ‘global learning outcomes’

  • People

    Project team Professor Clare Anderson Principal Investigator (British and French Empires) Ms Rachel Dawes Project Administrator Dr Christian De Vito Research Associate (Spain, Portugal and Latin America), 2013-18 Dr Lorraine Paterson Research Associate...

  • Unity is our strength why it is vital to stay in the EU

    Liz Kendall, MP for Leicester West and Labour's East Midlands EU Champion visited the University of Leicester’s new Centre for Medicine, which is part-funded by the European Union.

  • Leicester researcher examines differing factors behind forest fires

    A study of forest fires in the tropics has led a University of Leicester researcher to highlight the need to monitor ecosystems in more detail to try and prevent their destruction.

  • Honorary and emeritus staff

    Meet the honorary and emeritus staff under the health science department at the University of Leicester.

  • Awards

    The University of Leicester is proud to have achieved external recognition for our commitment to advancing equity, diversity and inclusion through the following charter marks and accreditations.

  • Greater empathy reduces problems with patient care

    Greater levels of compassion from hospital and clinical staff can reduce persistent problems with patient care says a University expert in empathy

  • Major funding for Leicester will help find new cancer treatments

    The search for new cancer treatments in Leicester is to receive a major funding investment of up to £2 million, providing future hope for people diagnosed with the disease.

  • 2019 news

    Browse news relating to the Division of Biomedical Services from 2019.

  • Mr Emmanuel Katsogridakis

    MD, MSc, PhD, MRCS British Heart Foundation Academic Clinical Lecturer Email  ek311@le.ac.

  • New study to explore how personalised drug doses could improve quality of life for people with secondary breast cancer

    A new study by a Leicester researcher will explore how people with incurable secondary (or metastatic) breast cancer experience treatment side effects, and whether personalised drug doses could help improve their quality of life

Back to top
MENU